title: [Correlation between chest examination with radiography, bronchoscopy and cytology of bronchial alveolar lavage in patients treated for small cell lung cancer].
abstract: In 129 SCLC patients (pts) 250 control fibrobronchoscopic (FOB) procedures were performed during chemotherapy. 71 pts had extensive disease and 58 limited disease. The evident correlation between radiologic and bronchoscopic assessment of tumor regression was confirmed in 60% of examinations. Tumor was visible during 16 bronchoscopic examinations in spite of complete regression on X-ray picture and on 53 chest X-ray examinations despite complete regression in the bronchi. Cancer cells found in 74 out of 250 bronchial washings samples were present significantly more often in these situations in which no regression of tumor in the bronchi was confirmed. Nevertheless tumor cells were also found in 3 out 57 cases in which complete regression on X-ray and in the bronchi was found. It was concluded that complete tumor regression on X-ray picture ought to be confirmed by bronchoscopy with cytologic examination of bronchial washing.
authors.affiliation: III Kliniki Gruźlicy i Chorób Płuc, Warszawie.
authors.forename: E
authors.initials: E
authors.lastname: Wiatr
authors.forename: M
authors.initials: M
authors.lastname: Pirozyński
authors.forename: I
authors.initials: I
authors.lastname: Bestry
authors.forename: D
authors.initials: D
authors.lastname: Szymańska
authors.forename: J
authors.initials: J
authors.lastname: Załeska
mesh_terms: D000328:Adult; D000368:Aged; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology*; D001999:Bronchoscopy; D018288:Carcinoma, Small Cell / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D005336:Fiber Optic Technology; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging* / Q000473:pathology; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011859:Radiography; D012074:Remission Induction
vernacular_title: Korelacja miedzy badaniami radiologicznymi klatki piersiowej, bronchoskopowymi i cytologicznymi wydzieliny oskrzelowej u chorych leczonych z powodu drobnokomórkowego raka płuca.